Achieve life sciences receives fda commissioner's national priority voucher for cytisinicline for treatment of nicotine dependence for e-cigarette or vaping cessation

Potential first-in-class treatment for nicotine e-cigarette or vaping cessation receives unprecedented expedited review pathway

ACHV Ratings Summary

ACHV Quant Ranking